Literature DB >> 27917700

Posterior reversible encephalopathy syndrome following elevated mean arterial pressures for cervical spinal cord injury.

Jeffrey H Zimering1, Addisu Mesfin2.   

Abstract

BACKGROUND: Increasing the mean arterial pressure (MAP) is an accepted treatment modality to minimize the risk for irreversible neurologic damage secondary to spinal cord ischemia. Posterior reversible encephalopathy syndrome (PRES) is a rare complication occurring after transplantation surgery, in persons having an autoimmune disorder or after abrupt increases in blood pressure of various etiologies. STUDY
DESIGN: Case report.
METHODS: Retrospective evaluation of medical records.
RESULTS: A 68-year-old female with long-standing diabetes, and rheumatoid arthritis (treated with methotrexate) presented with bilateral upper extremity weakness and numbness developing several days after a motor vehicle accident. Physical examination confirmed decreased upper extremity motor strength and decreased sensation to light touch and pinprick in the C5-C6 dermatomal distribution. Magnetic resonance imaging (MRI) demonstrated C5-C6 subluxation with spinal cord compression. The patient had traction applied and mean arterial pressures were elevated greater than 85 mmg. The following day the patient underwent anterior and posterior cervical spine fusion and decompression. Immediately post-operatively, the patient developed status epilepticus. Head MRI revealed areas of high T2 signal intensity in the bilateral occipital lobes, consistent with a diagnosis of PRES. Two weeks later, the patient had resolution of her symptoms and resolution of PRES on imaging.
CONCLUSION: This is the first report of posterior reversible encephalopathy syndrome secondary to therapeutic blood pressure increase in the setting of cervical spine fracture with neurological deficits. The patients had resolution of symptoms following discontinuation of the MAP goals. Posterior reversible encephalopathy syndrome (PRES) is a life-threatening condition characterized by seizures, confusion, visual disturbance, and headaches alongside neuroradiological findings indicative of posterior cerebral hemispheric white matter edema.1,2 PRES has been described in association with abrupt blood pressure elevation, autoimmune disorders, or transplantation.1-4 In this case report PRES presented with typical status epilepticus5 but in an unexpected clinical setting, immediately after anterior cervical decompression and fusion (ACDF) and posterior cervical fusion (PCF) with laminectomy of C5-C6.

Entities:  

Keywords:  Cervical fracture; MAP; Mean arterial pressure; PRES; Posterior reversible encephalopathy syndrome; SCI; Spinal cord injury

Mesh:

Year:  2016        PMID: 27917700      PMCID: PMC5810795          DOI: 10.1080/10790268.2016.1250030

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  27 in total

Review 1.  Guidelines for the management of acute cervical spine and spinal cord injuries.

Authors:  Mark N Hadley; Beverly C Walters; Paul A Grabb; Nelson M Oyesiku; Gregory J Przybylski; Daniel K Resnick; Timothy C Ryken; Debbie H Mielke
Journal:  Clin Neurosurg       Date:  2002

2.  Posterior reversible encephalopathy syndrome and oral methotrexate.

Authors:  Caroline Hart; Michael O Kinney; Mark O McCarron
Journal:  Clin Neurol Neurosurg       Date:  2012-01-04       Impact factor: 1.876

3.  Combined medical and surgical treatment after acute spinal cord injury: results of a prospective pilot study to assess the merits of aggressive medical resuscitation and blood pressure management.

Authors:  F L Vale; J Burns; A B Jackson; M N Hadley
Journal:  J Neurosurg       Date:  1997-08       Impact factor: 5.115

4.  Mean Arterial Blood Pressure Correlates with Neurological Recovery after Human Spinal Cord Injury: Analysis of High Frequency Physiologic Data.

Authors:  Gregory Hawryluk; William Whetstone; Rajiv Saigal; Adam Ferguson; Jason Talbott; Jacqueline Bresnahan; Sanjay Dhall; Jonathan Pan; Michael Beattie; Geoffrey Manley
Journal:  J Neurotrauma       Date:  2015-08-17       Impact factor: 5.269

5.  Posterior reversible encephalopathy after intrathecal methotrexate therapy in diffuse large B-cell lymphoma.

Authors:  Amit Patel; Robert Ayto; Donald H MacDonald
Journal:  Br J Haematol       Date:  2013-04-25       Impact factor: 6.998

6.  Autonomic dysreflexia-induced reversible posterior leukoencephalopathy syndrome in patients with spinal cord injury: two case reports.

Authors:  Kyung-Lim Joa; Yong-Il Shin; Huy Suh; Soo-Yeon Kim; Jae Hyeok Chang; Hyun-Yoon Ko
Journal:  J Spinal Cord Med       Date:  2013-05       Impact factor: 1.985

7.  Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings.

Authors:  Jennifer E Fugate; Daniel O Claassen; Harry J Cloft; David F Kallmes; Osman S Kozak; Alejandro A Rabinstein
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

Review 8.  A systematic review of the evidence supporting a role for vasopressor support in acute SCI.

Authors:  A Ploumis; N Yadlapalli; M G Fehlings; B K Kwon; A R Vaccaro
Journal:  Spinal Cord       Date:  2009-11-24       Impact factor: 2.772

9.  Endothelial injury, an intriguing effect of methotrexate and cyclophosphamide during hematopoietic stem cell transplantation in mice.

Authors:  L Zeng; Z Yan; S Ding; K Xu; L Wang
Journal:  Transplant Proc       Date:  2008-10       Impact factor: 1.066

Review 10.  Autonomic dysreflexia and posterior reversible encephalopathy syndrome.

Authors:  Ana Catarina Matias; João Rocha; Maria Emília Cerqueira; João Manuel Pereira
Journal:  Am J Phys Med Rehabil       Date:  2013-05       Impact factor: 2.159

View more
  1 in total

1.  Myelotomy promotes locomotor recovery in rats subjected to spinal cord injury: A meta-analysis of six randomized controlled trials.

Authors:  Chuan Qin; Wen-Hao Zhang; De-Gang Yang; Ming-Liang Yang; Liang-Jie Du; Jian-Jun Li
Journal:  Neural Regen Res       Date:  2018-06       Impact factor: 5.135

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.